Downregulation of TS, DPD, ERCC1, GST-Pi, EGFR, and HER2 gene expression after neoadjuvant three-modality treatment in patients with esophageal cancer

Journal of the American College of Surgeons

Volumn 200, Issue 3, 2005, Pages 336-344

  Schneider, Sylke ^a   Uchida, Kazumi ^a   Brabender, Jan ^c   Baldus, Stephan E ^c   Yochim, JiMin ^a   Danenberg, Kathleen D ^d   Salonga, Dennis ^d   Chen, Pei ^d   Tsao Wei, Denice ^b   Groshen, Susan ^b   Hoelscher, Arnulf H ^c   Schneider, Paul M ^c   Danenberg, Peter V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF COLOGNE   (Germany)

^d Response Genetics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DIHYDROPYRIMIDINE DEHYDROGENASE; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; FLUORESCENT DYE; FLUOROURACIL; GLUTATHIONE TRANSFERASE; MESSENGER RNA; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CHEMOSENSITIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ESOPHAGUS CANCER; FEMALE; GENE EXPRESSION; HUMAN; LASER MICRODISSECTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE;

EID: 20044379030     PISSN: 10727515     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jamcollsurg.2004.10.035     Document Type: Article

References (29)

1. D.H. Harpole Jr, M.B. Moore, J.E. Herndon 2nd The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer Clin Cancer Res 7 2001 562 569
2. Y. Hishikawa, S. Abe, S. Kinugasa Overexpression of metallothionein correlates with chemoresistance to cisplatin and prognosis in esophageal cancer Oncology 54 1997 342 347
3. K. Uchida, K. Hayashi, H. Kuramochi, K. Takasaki Changes in intratumoral thymidylate synthase (TS) and dihydropyrimidine dehydrogenase (DPD) mRNA expression in colorectal and gastric cancer during continuous tegafur infusion Int J Oncol 19 2001 341 346
4. E. Chu, J.L. Grem, P.G. Johnston, C.J. Allegra New concepts for the development and use of antifolates Stem Cells 14 1996 41 46
5. E. Chu, D.M. Koeller, P.G. Johnston Regulation of thymidylate synthase in human colon cancer cells treated with 5-fluorouracil and interferon-gamma Mol Pharmacol 43 1993 527 533
6. K. Keyomarsi, R.G. Moran Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells J Biol Chem 263 1988 14402 14409
7. J. Baselga, A.D. Seidman, P.P. Rosen, L. Norton HER2 overexpression and paclitaxel sensitivity in breast cancer therapeutic implications Oncology (Huntingt) 11 3 Suppl 2 1997 43 48
8. Z. Fan, J. Baselga, H. Masui, J. Mendelsohn Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts Cancer Res 53 1993 4637 4642
9. E. Bollschweiler, W. Schroder, A.H. Holscher, J.R. Siewert Preoperative risk analysis in patients with adenocarcinoma or squamous cell carcinoma of the oesophagus Br J Surg 87 2000 1106 1110
10. D.J. Adelstein, T.W. Rice, M. Becker Use of concurrent chemotherapy, accelerated fractionation radiation, and surgery for patients with esophageal carcinoma Cancer 80 1997 1011 1020
11. K. Junker, M. Thomas, K. Schulmann Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment J Cancer Res Clin Oncol 123 1997 469 477
12. th ed 1997 John Wiley & Sons New York
13. R.V. Lord, D. Salonga, K.D. Danenberg Telomerase reverse transcriptase expression is increased early in the Barrett's metaplasia, dysplasia, adenocarcinoma sequence J Gastrointest Surg 4 2000 135 142
14. U.E. Gibson, C.A. Heid, P.M. Williams A novel method for real time quantitative RT-PCR Genome Res 6 1996 995 1001
15. M. Nishiyama, W. Yamamoto, J.S. Park Low-dose cisplatin and 5-fluorouracil in combination can repress increased gene expression of cellular resistance determinants to themselves Clin Cancer Res 5 1999 2620 2628
16. G.J. Peters, H.H. Backus, S. Freemantle Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism Biochim Biophys Acta 1587 2002 194 205
17. A. Yacoub, J.S. Park, L. Qiao MAPK dependence of DNA damage repair ionizing radiation and the induction of expression of the DNA repair genes XRCC1 and ERCC1 in DU145 human prostate carcinoma cells in a MEK1/2 dependent fashion Int J Radiat Biol 77 2001 1067 1078
18. R.K. Schmidt-Ullrich, K.C. Valerie, W. Chan, D. McWilliams Altered expression of epidermal growth factor receptor and estrogen receptor in MCF-7 cells after single and repeated radiation exposures Int J Radiat Oncol Biol Phys 29 1994 813 819
19. M. Hagan, L. Wang, J.R. Hanley Ionizing radiation-induced mitogen-activated protein (MAP) kinase activation in DU145 prostate carcinoma cells MAP kinase inhibition enhances radiation-induced cell killing and G2/M-phase arrest Radiat Res 153 2000 371 383
20. S.P. Ethier, T.S. Lawrence Epidermal growth factor receptor signaling and response of cancer cells to ionizing radiation J Natl Cancer Inst 93 2001 890 891
21. K. Keyomarsi, J. Samet, G. Molnar, A.B. Pardee The thymidylate synthase inhibitor, ICI D1694, overcomes translational detainment of the enzyme J Biol Chem 268 1993 15142 15149
22. P.M. Harari, S.M. Huang Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling Semin Radiat Oncol 11 2001 281 289
23. T. Akimoto, N.R. Hunter, L. Buchmiller Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas Clin Cancer Res 5 1999 2884 2890
24. K. Wosikowski, D. Schuurhuis, K. Johnson Identification of epidermal growth factor receptor and c-erbB2 pathway inhibitors by correlation with gene expression patterns J Natl Cancer Inst 89 1997 1505 1515
25. S.M. Huang, P.M. Harari Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis Clin Cancer Res 6 2000 2166 2174
26. L. Milas, K. Mason, N. Hunter In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody Clin Cancer Res 6 2000 701 708
27. D.M. Shin, N.J. Donato, R. Perez-Soler Epidermal growth factor receptor-targeted therapy with C225 and cisplatin in patients with head and neck cancer Clin Cancer Res 7 2001 1204 1213
28. S. Nasu, K.K. Ang, Z. Fan, L. Milas C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability Int J Radiat Oncol Biol Phys 51 2001 474 477
29. J. Mendelsohn, J. Baselga The EGF receptor family as targets for cancer therapy Oncogene 19 2000 6550 6565